Holders — by stockHoldings — by fund
Seven Fleet Capital Management LP
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-06-30 · filed with the SEC up to 45 days after quarter end · CIK 0002092021
$605.9M
disclosed book value
96
positions
22.1%
largest position share
Positions, as of 2026-06-30
top 96 of 96 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | CGONCG ONCOLOGY INC | 1.9M | $134.0M | 22.1% |
| 2 | TNGXTANGO THERAPEUTICS INC | 3.2M | $95.7M | 15.8% |
| 3 | RVMDREVOLUTION MEDICINES INC | 242,029 | $45.3M | 7.5% |
| 4 | PHARVARIS N V | 774,501 | $26.8M | 4.4% |
| 5 | LQDALIQUIDIA CORPORATION | 256,603 | $20.5M | 3.4% |
| 6 | ELVNENLIVEN THERAPEUTICS INC | 365,386 | $18.5M | 3.1% |
| 7 | ABVXABIVAX SA | 111,334 | $14.8M | 2.4% |
| 8 | AVTXAVALO THERAPEUTICS INC | 770,765 | $14.2M | 2.4% |
| 9 | MIRMMIRUM PHARMACEUTICALS INC | 110,393 | $12.9M | 2.1% |
| 10 | ASMBASSEMBLY BIOSCIENCES INC | 433,147 | $11.9M | 2% |
| 11 | IPSCCENTURY THERAPEUTICS INC | 4.3M | $10.7M | 1.8% |
| 12 | CYTKCYTOKINETICS INC | 118,240 | $10.1M | 1.7% |
| 13 | TSHATAYSHA GENE THERAPIES INC | 1.5M | $9.9M | 1.6% |
| 14 | MANEVERADERMICS INC | 80,000 | $9.8M | 1.6% |
| 15 | AVBPARRIVENT BIOPHARMA INC | 246,606 | $8.6M | 1.4% |
| 16 | TARSTARSUS PHARMACEUTICALS INC | 117,067 | $7.9M | 1.3% |
| 17 | XNCRXENCOR INC | 368,305 | $7.8M | 1.3% |
| 18 | ROIVANT SCIENCES LTD | 220,126 | $7.8M | 1.3% |
| 19 | DAMORA THERAPEUTICS INC | 284,430 | $7.4M | 1.2% |
| 20 | AXSMAXSOME THERAPEUTICS INC | 28,826 | $7.1M | 1.2% |
| 21 | DFTXDEFINIUM THERAPEUTICS INC | 148,647 | $7.0M | 1.2% |
| 22 | DNTHDIANTHUS THERAPEUTICS INC | 64,723 | $6.3M | 1% |
| 23 | COGTCOGENT BIOSCIENCES INC | 147,510 | $5.7M | 0.9% |
| 24 | ERASERASCA INC | 308,007 | $5.6M | 0.9% |
| 25 | PTGXPROTAGONIST THERAPEUTICS INC | 45,400 | $5.6M | 0.9% |
| 26 | NERVMINERVA NEUROSCIENCES INC | 1.0M | $5.6M | 0.9% |
| 27 | EDITEDITAS MEDICINE INC | 1.3M | $4.3M | 0.7% |
| 28 | CTMXCYTOMX THERAPEUTICS INC. | 1.1M | $4.1M | 0.7% |
| 29 | EPRXEUPRAXIA PHARMACEUTICALS INC | 610,785 | $4.0M | 0.7% |
| 30 | STROSUTRO BIOPHARMA INC | 159,118 | $3.8M | 0.6% |
| 31 | RLAYRELAY THERAPEUTICS INC | 178,222 | $3.3M | 0.6% |
| 32 | CLDXCELLDEX THERAPEUTICS INC NEW | 86,664 | $3.2M | 0.5% |
| 33 | ASCENDIS PHARMA A/S | 11,869 | $3.2M | 0.5% |
| 34 | SGMTSAGIMET BIOSCIENCES INC | 403,545 | $3.1M | 0.5% |
| 35 | ZLABZAI LAB LTD | 136,016 | $2.9M | 0.5% |
| 36 | SABSSAB BIOTHERAPEUTICS INC | 736,077 | $2.9M | 0.5% |
| 37 | MDGLMADRIGAL PHARMACEUTICALS INC | 4,973 | $2.7M | 0.4% |
| 38 | PRAXPRAXIS PRECISION MEDICINES I | 7,540 | $2.5M | 0.4% |
| 39 | RLMDRELMADA THERAPEUTICS INC | 348,265 | $2.4M | 0.4% |
| 40 | AGIOAGIOS PHARMACEUTICALS INC | 56,900 | $2.1M | 0.3% |
| 41 | XENEXENON PHARMACEUTICALS INC | 33,300 | $2.1M | 0.3% |
| 42 | SVRASAVARA INC | 309,103 | $1.9M | 0.3% |
| 43 | CCCCC4 THERAPEUTICS INC | 381,169 | $1.8M | 0.3% |
| 44 | PCVXVAXCYTE INC | 29,800 | $1.8M | 0.3% |
| 45 | CELCCELCUITY INC | 16,252 | $1.7M | 0.3% |
| 46 | SNDXSYNDAX PHARMACEUTICALS INC | 77,930 | $1.6M | 0.3% |
| 47 | ZNTLZENTALIS PHARMACEUTICALS INC | 317,600 | $1.5M | 0.2% |
| 48 | GPCRSTRUCTURE THERAPEUTICS INC | 26,800 | $1.4M | 0.2% |
| 49 | LONALEONABIO INC | 154,153 | $1.4M | 0.2% |
| 50 | IDYAIDEAYA BIOSCIENCES INC | 37,865 | $1.4M | 0.2% |
| 51 | GERNGERON CORP | 1.1M | $1.4M | 0.2% |
| 52 | ANLADLAI NORYTE LTD | 113,207 | $1.3M | 0.2% |
| 53 | CRVSCORVUS PHARMACEUTICALS INC | 82,890 | $1.2M | 0.2% |
| 54 | ALKERMES PLC | 23,285 | $1.2M | 0.2% |
| 55 | SYRESPYRE THERAPEUTICS INC | 13,300 | $1.2M | 0.2% |
| 56 | CATXPERSPECTIVE THERAPEUTICS INC | 332,613 | $1.1M | 0.2% |
| 57 | OKURONKURE THERAPEUTICS INC | 240,963 | $1.1M | 0.2% |
| 58 | SMMTSUMMIT THERAPEUTICS INC | 73,300 | $1.1M | 0.2% |
| 59 | ANTXAN2 THERAPEUTICS INC | 208,946 | $1.0M | 0.2% |
| 60 | CTNMCONTINEUM THERAPEUTICS INC | 60,541 | $992,267 | 0.2% |
| 61 | TRVITREVI THERAPEUTICS INC | 45,598 | $833,430 | 0.1% |
| 62 | VYGRVOYAGER THERAPEUTICS INC | 230,406 | $771,860 | 0.1% |
| 63 | IVAINVENTIVA SA | 200,141 | $756,533 | 0.1% |
| 64 | ENGNENGENE THERAPEUTICS INC | 411,065 | $711,142 | 0.1% |
| 65 | LRMRLARIMAR THERAPEUTICS INC | 230,921 | $704,309 | 0.1% |
| 66 | IKTINHIBIKASE THERAPEUTICS INC | 346,900 | $704,207 | 0.1% |
| 67 | NGNENEUROGENE INC | 22,060 | $693,787 | 0.1% |
| 68 | IHIISHARES TR | 13,800 | $681,858 | 0.1% |
| 69 | SLNSILENCE THERAPEUTICS PLC | 60,107 | $659,975 | 0.1% |
| 70 | KRYSKRYSTAL BIOTECH INC | 1,774 | $659,343 | 0.1% |
| 71 | IRDOPUS GENETICS INC | 143,137 | $588,293 | 0.1% |
| 72 | PALIPALISADE BIO INC | 272,204 | $568,906 | 0.1% |
| 73 | EOLSEVOLUS INC | 78,057 | $541,716 | 0.1% |
| 74 | UNCYUNICYCIVE THERAPEUTICS INC | 103,400 | $521,136 | 0.1% |
| 75 | CMPXCOMPASS THERAPEUTICS INC | 233,066 | $510,415 | 0.1% |
| 76 | BCRXBIOCRYST PHARMACEUTICALS INC | 51,024 | $510,240 | 0.1% |
| 77 | DRUGBRIGHT MINDS BIOSCIENCES INC | 6,395 | $448,929 | 0.1% |
| 78 | PROTHENA CORP PLC | 43,300 | $423,907 | 0.1% |
| 79 | GLUEMONTE ROSA THERAPEUTICS INC | 16,800 | $406,560 | 0.1% |
| 80 | OLMAOLEMA PHARMACEUTICALS INC | 31,476 | $393,765 | 0.1% |
| 81 | MISTMILESTONE PHARMACEUTICALS IN | 270,233 | $362,112 | 0.1% |
| 82 | ENTERA BIO LTD | 191,354 | $338,697 | 0.1% |
| 83 | CUECUE BIOPHARMA INC | 10,702 | $337,755 | 0.1% |
| 84 | MBXMBX BIOSCIENCES INC | 6,000 | $331,200 | 0.1% |
| 85 | BEAMBEAM THERAPEUTICS INC | 8,804 | $302,153 | 0% |
| 86 | ASTRAZENECA PLC | 1,400 | $265,468 | 0% |
| 87 | AMLXAMYLYX PHARMACEUTICALS INC | 14,540 | $261,138 | 0% |
| 88 | STOKSTOKE THERAPEUTICS INC | 7,745 | $255,353 | 0% |
| 89 | VKTXVIKING THERAPEUTICS INC | 7,404 | $251,884 | 0% |
| 90 | LPCNLIPOCINE INC NEW | 78,842 | $201,836 | 0% |
| 91 | CRBPCORBUS PHARMACEUTICALS HLDGS | 21,432 | $201,032 | 0% |
| 92 | PMNPROMIS NEUROSCIENCES INC | 10,600 | $139,496 | 0% |
| 93 | WAVE LIFE SCIENCES LTD | 19,048 | $99,812 | 0% |
| 94 | PMVPPMV PHARMACEUTICALS INC | 53,569 | $71,782 | 0% |
| 95 | FULCFULCRUM THERAPEUTICS INC | 18,089 | $66,206 | 0% |
| 96 | UNIQURE NV | 338 | $15,254 | 0% |
Source: SEC Form 13F-HR, reporting period 2026-06-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.